Coronary ostial lesions remain among the most challenging lesions encountered in interventional cardiology because of their complex anatomy, frequent angiographic ambiguity, and high risk of procedural complications. Precise differentiation between true ostial disease, proximal vessel involvement, and left main coronary artery extension is crucial for optimal therapeutic planning. Intravascular imaging has emerged as an essential tool in this setting by providing accurate lesion characterization and guidance for intervention. We report the case of a 72-year-old man with multiple cardiovascular comorbidities, including diabetes mellitus, hypertension, chronic kidney disease requiring hemodialysis, and a history of multivessel percutaneous coronary intervention. He presented with recurrent deterioration of left ventricular systolic function and elevated NT-proBNP levels. Coronary angiography demonstrated a severe stenosis involving the ostium of the left anterior descending artery; however, angiographic assessment alone could not determine whether the lesion represented true ostial in-stent restenosis or extension into the distal left main coronary artery. Intravascular ultrasound was therefore performed and confirmed isolated ostial left anterior descending artery in-stent restenosis due predominantly to neointimal hyperplasia. The lesion was successfully treated using excimer laser coronary atherectomy followed by high-pressure balloon dilatation and paclitaxel-coated balloon angioplasty under intravascular ultrasound guidance. This case highlights the critical role of intravascular imaging in the diagnosis and treatment of complex ostial coronary lesions and illustrates a contemporary strategy for managing ostial in-stent restenosis while avoiding additional stent implantation.
References
[1]
Johnson, T.W., R?ber, L., di Mario, C., et al. (2019) Clinical Use of Intracoronary Imaging. Part 2: Acute Coronary Syndromes, Ambiguous Coronary Angiography Findings, and Guiding Interventional Decision-Making: An Expert Consensus Document of the European Association of Percutaneous Cardiovascular Interventions. European Heart Journal, 40, 2566-2584. https://pubmed.ncbi.nlm.nih.gov/31112213/
[2]
Neumann, F.J., Sousa-Uva, M., Ahlsson, A., et al. (2019) 2018 ESC Guidelines on Myocardial Revascularization. European Heart Journal, 40, 87-165.
[3]
Moussa, I.D., Mohananey, D., Saucedo, J., Stone, G.W., Yeh, R.W., Kennedy, K.F., etal. (2020) Trends and Outcomes of Restenosis after Coronary Stent Implantation in the United States. JournaloftheAmericanCollegeofCardiology, 76, 1521-1531. https://doi.org/10.1016/j.jacc.2020.08.002
[4]
R?ber, L., Mintz, G.S., Koskinas, K.C., Johnson, T.W., Holm, N.R., Onuma, Y., etal. (2018) Clinical Use of Intracoronary Imaging. Part 1: Guidance and Optimization of Coronary Interventions. An Expert Consensus Document of the European Association of Percutaneous Cardiovascular Interventions. EuropeanHeartJournal, 39, 3281-3300. https://doi.org/10.1093/eurheartj/ehy285
[5]
Mintz, G.S., Popma, J.J., Pichard, A.D., et al. (1996) Intravascular Ultrasound Assessment of the Mechanisms and Predictors of Restenosis Following Coronary Angioplasty. Journal of Invasive Cardiology, 8, 1-14. https://pubmed.ncbi.nlm.nih.gov/10785680/
Buccheri, D., Piraino, D., Andolina, G. and Cortese, B. (2016) Understanding and Managing In-Stent Restenosis: A Review of Clinical Data, from Pathogenesis to Treatment. JournalofThoracicDisease, 8, E1150-E1162. https://doi.org/10.21037/jtd.2016.10.93
[8]
Giustino, G., Colombo, A., Camaj, A., Yasumura, K., Mehran, R., Stone, G.W., etal. (2022) Coronary In-Stent Restenosis. JournaloftheAmericanCollegeofCardiology, 80, 348-372. https://doi.org/10.1016/j.jacc.2022.05.017
[9]
Jeger, R.V., Eccleshall, S., Wan Ahmad, W.A., Ge, J., Poerner, T.C., Shin, E., etal. (2020) Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group. JACC: CardiovascularInterventions, 13, 1391-1402. https://doi.org/10.1016/j.jcin.2020.02.043
[10]
Giacoppo, D., Alfonso, F., Xu, B., Claessen, B.E.P.M., Adriaenssens, T., Jensen, C., etal. (2020) Drug-Coated Balloon Angioplasty versus Drug-Eluting Stent Implantation in Patients with Coronary Stent Restenosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. JournaloftheAmericanCollegeofCardiology, 75, 2664-2678. https://doi.org/10.1016/j.jacc.2020.04.006
[11]
Scheller, B., Hehrlein, C., Bocksch, W., Rutsch, W., Haghi, D., Dietz, U., etal. (2006) Treatment of Coronary In-Stent Restenosis with a Paclitaxel-Coated Balloon Catheter. NewEnglandJournalofMedicine, 355, 2113-2124. https://doi.org/10.1056/nejmoa061254
[12]
Byrne, R.A., Neumann, F., Mehilli, J., Pinieck, S., Wolff, B., Tiroch, K., etal. (2013) Paclitaxel-eluting Balloons, Paclitaxel-Eluting Stents, and Balloon Angioplasty in Patients with Restenosis after Implantation of a Drug-Eluting Stent (ISAR-DESIRE 3): A Randomised, Open-Label Trial. TheLancet, 381, 461-467. https://doi.org/10.1016/s0140-6736(12)61964-3
[13]
Alfonso, F., Pérez-Vizcayno, M.J., Cárdenas, A., García del Blanco, B., García-Touchard, A., López-Minguéz, J.R., etal. (2015) A Prospective Randomized Trial of Drug-Eluting Balloons versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis of Drug-Eluting Stents: The RIBS IV Randomized Clinical Trial. JournaloftheAmericanCollege of Cardiology, 66, 23-33. https://doi.org/10.1016/j.jacc.2015.04.063
[14]
Egred, M. and Brilaki, E.S. (2020) Excimer Laser Coronary Angioplasty (ELCA): Fundamentals, Mechanism of Action, and Clinical Applications. Journal of Invasive Cardiology, 32, E27-E35. https://pubmed.ncbi.nlm.nih.gov/32005787/
[15]
Miyazaki, T., Ashikaga, T., Fukushima, T., Hatano, Y., Sasaoka, T., Kurihara, K., etal. (2019) Treatment of In-Stent Restenosis by Excimer Laser Coronary Atherectomy and Drug-Coated Balloon: Serial Assessment with Optical Coherence Tomography. JournalofInterventionalCardiology, 2019, Article ID: 6515129. https://doi.org/10.1155/2019/6515129